Kewalramani Reshma bought VRTX
January 22, 2026 · Form 4 insider transaction
Kewalramani Reshma bought 11,885 shares of Vertex Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,885
Price
$0.00
Total value
N/A
InsiderKewalramani Reshma
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 22, 2026
Filing dateJanuary 26, 2026
Shares owned after154,825
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents earned performance shares with respect to a performance stock unit award granted on 02/12/2025 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 01/22/2026 and the shares will vest in installments beginning on 02/24/2026.